Carlos Fernández de Larrea was born in 1978. He studied medicine at the Central University of Venezuela in Caracas, obtaining the distinction Summa Cum Laude. He moved to Barcelona where he completed his training in Hematology at Hospital Clínic. His doctoral thesis was on complete remission in multiple myeloma, obtaining the Extraordinary Award of the University of Barcelona in 2012. He has spent training periods at the Institut Pasteur in Paris, the Centre for Systemic Amyloidosis of Pavia and the National Cancer Institute (NIH) in Bethesda. He is currently medical staff of the Department of Hematology at Hospital Clínic de Barcelona, Junior Researcher Leader group in the IDIBAPS, Associate Professor of Medicine in the University of Barcelona and member of the Amyloidosis and Myeloma Unit, as well as Visiting Investigator at Memorial Sloan Kettering Cancer Center in New York.  

His skills and experience include proven experience in medical research, more than 50 articles on hematology, including original articles, editorials, revisions and clinical guidelines, with an impact factor over 200 points and more than 100 as a first author. In fact, his manuscripts have been published in journals such as Blood, Leukemia, Journal of Clinical Oncology, Haematologica and Clinical Cancer Research. He gives regularly oral and poster presentations for the national and international meetings in Hematology. He also partipates actively in clinical trials as principal researcher as well as collaborator in phase I, II and III trials in multiple myeloma, amyloidosis and macroglobulinemia.